Park, B-B <br/><br/>
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.  [electronic resource] 

 -  Leukemia & lymphoma  Dec 2005 
 - 1743-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428190500178266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lymphoma, T-Cell--mortality<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Prednisone--administration & dosage<br/>Recurrence<br/>Retrospective Studies<br/>Salvage Therapy<br/>Stem Cell Transplantation<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage